Your browser doesn't support javascript.
loading
All-trans retinoic acid plus high-dose dexamethasone as first-line treatment for patients with newly diagnosed immune thrombocytopenia: a multicentre, open-label, randomised, controlled, phase 2 trial.
Huang, Qiu-Sha; Liu, Yi; Wang, Jing-Bo; Peng, Jun; Hou, Ming; Liu, Hui; Feng, Ru; Wang, Jing-Wen; Xu, Lan-Ping; Wang, Yang; Huang, Xiao-Jun; Zhang, Xiao-Hui.
Afiliación
  • Huang QS; Peking University Institute of Hematology, Peking University People's Hospital, Beijing, China; National Clinical Research Center for Hematologic Disease, Beijing, China; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China; Collaborative Innovation Center of Hematology,
  • Liu Y; Department of Hematology, The Sixth Medical Center of PLA General Hospital, Beijing, China.
  • Wang JB; Department of Hematology, Beijing Aerospace General Hospital, Beijing, China.
  • Peng J; Department of Hematology, Qilu Hospital, Shandong University, Jinan, China.
  • Hou M; Department of Hematology, Qilu Hospital, Shandong University, Jinan, China.
  • Liu H; Department of Hematology, National Centre of Gerontology, Beijing Hospital, Beijing, China.
  • Feng R; Department of Hematology, National Centre of Gerontology, Beijing Hospital, Beijing, China.
  • Wang JW; Department of Hematology, Beijing Tongren Hospital, Beijing, China.
  • Xu LP; Peking University Institute of Hematology, Peking University People's Hospital, Beijing, China; National Clinical Research Center for Hematologic Disease, Beijing, China; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China; Collaborative Innovation Center of Hematology,
  • Wang Y; Biological Information and Statistics Center, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Huang XJ; Peking University Institute of Hematology, Peking University People's Hospital, Beijing, China; National Clinical Research Center for Hematologic Disease, Beijing, China; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China; Collaborative Innovation Center of Hematology,
  • Zhang XH; Peking University Institute of Hematology, Peking University People's Hospital, Beijing, China; National Clinical Research Center for Hematologic Disease, Beijing, China; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China; Collaborative Innovation Center of Hematology,
Lancet Haematol ; 8(10): e688-e699, 2021 Oct.
Article en En | MEDLINE | ID: mdl-34560012
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tretinoina / Dexametasona / Púrpura Trombocitopénica Idiopática Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Lancet Haematol Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tretinoina / Dexametasona / Púrpura Trombocitopénica Idiopática Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Lancet Haematol Año: 2021 Tipo del documento: Article